Elevated stearoyl-CoA desaturase-1 expression in skeletal muscle contributes to abnormal fatty acid partitioning in obese humans.

[1]  L. Baur,et al.  Skeletal muscle membrane lipids and insulin resistance , 2007, Lipids.

[2]  E. Tapscott,et al.  Lipid content and fatty acid composition of heart and muscle of the BIO 82.62 cardiomyopathic hamster , 1976, Lipids.

[3]  J. Friedman,et al.  Stearoyl-CoA desaturase-1 deficiency reduces ceramide synthesis by downregulating serine palmitoyltransferase and increasing beta-oxidation in skeletal muscle. , 2005, American journal of physiology. Endocrinology and metabolism.

[4]  D. L. Norwood,et al.  Tandem mass spectrometry: A new method for acylcarnitine profiling with potential for neonatal screening for inborn errors of metabolism , 1990, Journal of Inherited Metabolic Disease.

[5]  Peter A. Jones,et al.  Epigenetics in human disease and prospects for epigenetic therapy , 2004, Nature.

[6]  J. Friedman,et al.  Stearoyl-CoA desaturase 1 deficiency increases fatty acid oxidation by activating AMP-activated protein kinase in liver. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[7]  David Millington,et al.  Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistance , 2004, Nature Medicine.

[8]  M. Miyazaki,et al.  Regulation of stearoyl-CoA desaturases and role in metabolism. , 2004, Progress in lipid research.

[9]  H. Beck-Nielsen,et al.  Reduced lipid oxidation in skeletal muscle from type 2 diabetic subjects may be of genetic origin: evidence from cultured myotubes. , 2004, Diabetes.

[10]  Avrum Spira,et al.  Guidelines: Expression profiling — best practices for data generation and interpretation in clinical trials , 2004 .

[11]  R. Waterland,et al.  Early nutrition, epigenetic changes at transposons and imprinted genes, and enhanced susceptibility to adult chronic diseases. , 2004, Nutrition.

[12]  M. Miyazaki,et al.  Stearoyl-CoA desaturase 1 deficiency elevates insulin-signaling components and down-regulates protein-tyrosine phosphatase 1B in muscle , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[13]  G. Shulman,et al.  Skeletal muscle lipid metabolism with obesity. , 2003, American journal of physiology. Endocrinology and metabolism.

[14]  E. Schleicher,et al.  Glucose oversupply increases Δ9-desaturase expression and its metabolites in rat skeletal muscle , 2003, Diabetologia.

[15]  Eric P Hoffman,et al.  Response of rat muscle to acute resistance exercise defined by transcriptional and translational profiling , 2002, The Journal of physiology.

[16]  W. Kraus,et al.  Adiponectin is not altered with exercise training despite enhanced insulin action. , 2002, American journal of physiology. Endocrinology and metabolism.

[17]  B. Yandell,et al.  Loss of stearoyl–CoA desaturase-1 function protects mice against adiposity , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[18]  W. Kraus,et al.  Fatty Acid Homeostasis and Induction of Lipid Regulatory Genes in Skeletal Muscles of Peroxisome Proliferator-activated Receptor (PPAR) α Knock-out Mice , 2002, The Journal of Biological Chemistry.

[19]  N. Socci,et al.  Role for Stearoyl-CoA Desaturase-1 in Leptin-Mediated Weight Loss , 2002, Science.

[20]  Kirk W. Johnson,et al.  Inhibition of glycogen synthase kinase 3 improves insulin action and glucose metabolism in human skeletal muscle. , 2002, Diabetes.

[21]  S. Kliewer,et al.  Peroxisome Proliferator-Activated Receptor-α Regulates Fatty Acid Utilization in Primary Human Skeletal Muscle Cells , 2002 .

[22]  S. Kliewer,et al.  Peroxisome proliferator-activated receptor-alpha regulates fatty acid utilization in primary human skeletal muscle cells. , 2002, Diabetes.

[23]  B. Goodpaster,et al.  Fat content in individual muscle fibers of lean and obese subjects , 2001, International Journal of Obesity.

[24]  Y. C. Kim,et al.  A lipogenic diet in mice with a disruption of the stearoyl-CoA desaturase 1 gene reveals a stringent requirement of endogenous monounsaturated fatty acids for triglyceride synthesis. , 2001, Journal of lipid research.

[25]  M. D. Leibowitz,et al.  Differential effects of rexinoids and thiazolidinediones on metabolic gene expression in diabetic rodents. , 2001, Molecular pharmacology.

[26]  T. Willson,et al.  Comprehensive Messenger Ribonucleic Acid Profiling Reveals That Peroxisome Proliferator-Activated Receptor γ Activation Has Coordinate Effects on Gene Expression in Multiple Insulin-Sensitive Tissues. , 2001, Endocrinology.

[27]  G. Cooney,et al.  Peroxisome Proliferator—Activated Receptor (PPAR)-α Activation Lowers Muscle Lipids and Improves Insulin Sensitivity in High Fat—Fed Rats Comparison With PPAR-γ Activation , 2001 .

[28]  T. Willson,et al.  Comprehensive messenger ribonucleic acid profiling reveals that peroxisome proliferator-activated receptor gamma activation has coordinate effects on gene expression in multiple insulin-sensitive tissues. , 2001, Endocrinology.

[29]  G. Cooney,et al.  Peroxisome proliferator-activated receptor (PPAR)-alpha activation lowers muscle lipids and improves insulin sensitivity in high fat-fed rats: comparison with PPAR-gamma activation. , 2001, Diabetes.

[30]  M. Miyazaki,et al.  The Biosynthesis of Hepatic Cholesterol Esters and Triglycerides Is Impaired in Mice with a Disruption of the Gene for Stearoyl-CoA Desaturase 1* , 2000, The Journal of Biological Chemistry.

[31]  G. Dohm,et al.  Involvement of protein kinase C in human skeletal muscle insulin resistance and obesity. , 2000, Diabetes.

[32]  Simon C Watkins,et al.  Intramuscular lipid content is increased in obesity and decreased by weight loss. , 2000, Metabolism: clinical and experimental.

[33]  G. Shulman,et al.  Mechanism of Insulin Resistance in A-ZIP/F-1 Fatless Mice* , 2000, The Journal of Biological Chemistry.

[34]  G. Dohm,et al.  Protein kinase C modulates insulin action in human skeletal muscle. , 2000, American journal of physiology. Endocrinology and metabolism.

[35]  G. Shulman,et al.  Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice. , 2000, The Journal of clinical investigation.

[36]  Margaret S. Wu,et al.  Role of Skeletal Muscle in Thiazolidinedione Insulin Sensitizer ( PPAR g Agonist ) Action , 1998 .

[37]  J. Olefsky,et al.  Skeletal muscle peroxisome proliferator- activated receptor-gamma expression in obesity and non- insulin-dependent diabetes mellitus. , 1998, The Journal of clinical investigation.

[38]  E. Kraegen,et al.  Reversal of chronic alterations of skeletal muscle protein kinase C from fat-fed rats by BRL-49653. , 1997, American journal of physiology. Endocrinology and metabolism.

[39]  S. Mudaliar,et al.  PPAR-γ Gene Expression Is Elevated in Skeletal Muscle of Obese and Type II Diabetic Subjects , 1997, Diabetes.

[40]  S. Mudaliar,et al.  PPAR-gamma gene expression is elevated in skeletal muscle of obese and type II diabetic subjects. , 1997, Diabetes.

[41]  S. Mudaliar,et al.  Glycogen synthase activity is reduced in cultured skeletal muscle cells of non-insulin-dependent diabetes mellitus subjects. Biochemical and molecular mechanisms. , 1996, The Journal of clinical investigation.

[42]  R. Henry,et al.  Insulin Action and Glucose Metabolism in Nondiabetic Control and NIDDM Subjects: Comparison Using Human Skeletal Muscle Cell Cultures , 1995, Diabetes.

[43]  F. Giorgino,et al.  Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects. , 1995, The Journal of clinical investigation.

[44]  J. Ntambi,et al.  The regulation of stearoyl-CoA desaturase (SCD). , 1995, Progress in lipid research.

[45]  W. Pories,et al.  Cellular alterations in liver, skeletal muscle, and adipose tissue responsible for insulin resistance in obesity and type II diabetes. , 1989, Diabetes/metabolism reviews.

[46]  K. Kaestner,et al.  Differentiation-induced gene expression in 3T3-L1 preadipocytes. Characterization of a differentially expressed gene encoding stearoyl-CoA desaturase. , 1988, The Journal of biological chemistry.

[47]  G. Dohm,et al.  An in vitro human muscle preparation suitable for metabolic studies. Decreased insulin stimulation of glucose transport in muscle from morbidly obese and diabetic subjects. , 1988, The Journal of clinical investigation.

[48]  J. McGarry,et al.  Interaction of malonyl-CoA and related compounds with mitochondria from different rat tissues. Relationship between ligand binding and inhibition of carnitine palmitoyltransferase I. , 1983, The Biochemical journal.

[49]  H. Enoch,et al.  Mechanism of rat liver microsomal stearyl-CoA desaturase. Studies of the substrate specificity, enzyme-substrate interactions, and the function of lipid. , 1976, The Journal of biological chemistry.

[50]  W. J. Dyer,et al.  A rapid method of total lipid extraction and purification. , 1959, Canadian journal of biochemistry and physiology.